Skip to content
Dx

ICD-10-CM 2027 diagnosis code

T36.2X3APoisoning by chloramphenicol group, assault, initial encounter

✓ Billable / specificRequires 7th character

T36.2X3A is a valid, billable ICD-10-CM code for poisoning by chloramphenicol group, assault, initial encounter. It can be reported on claims for dates of service from October 1, 2026 – September 30, 2027.Short description: Poisoning by chloramphenicol group, assault, init encntr

Code unchanged since ICD-10-CM took effect on October 1, 2015. Source: official FY2027 ICD-10-CM release from CDC/NCHS and CMS. Page updated September 29, 2026. About our data

About T36.2X3A

T36.2X3A is the ICD-10-CM diagnosis code for poisoning by chloramphenicol group, assault, initial encounter. It belongs to category T36 (poisoning by, adverse effect of and underdosing of systemic antibiotics), block T36-T50 (poisoning by, adverse effects of and underdosing of drugs, medicaments and biological substances) and chapter 19 (injury, poisoning and certain other consequences of external causes). It is billable, so it can be reported on its own for dates of service from October 1, 2026 through September 30, 2027.

The 7th character "A" means initial encounter: use it while the patient is receiving active treatment for the condition.

It is not a CC or MCC, so as a secondary diagnosis it doesn't change the MS-DRG severity level.

In MS-DRG v44.0, it is part of the grouping logic for DRG 917 (Poisoning and Toxic Effects of Drugs with MCC, relative weight 1.57) and DRG 918 (Poisoning and Toxic Effects of Drugs without MCC, relative weight 0.872), in MDC 21 (Injuries, Poisonings and Toxic Effects of Drugs), as a principal or secondary diagnosis. The DRG a claim lands in depends on the principal diagnosis, procedures and any CC/MCC secondary diagnoses.

It has been part of ICD-10-CM since the code set took effect on October 1, 2015 and hasn't changed since.

Before ICD-10, this condition was coded in ICD-9-CM as 960.2 (poisoning by chloramphenicol group) and E962.0 (assault by drugs and medicinal substances).

7th character

Ainitial encounter

Other encounter types for T36.2X3:

Notes that apply from higher levels

Instructions written at a parent level also apply to T36.2X3A.

› From T36 Poisoning by, adverse effect of and underdosing of systemic antibiotics
Excludes1
  • antineoplastic antibiotics (T45.1-)
  • locally applied antibiotic NEC (T49.0)
  • topically used antibiotic for ear, nose and throat (T49.6)
  • topically used antibiotic for eye (T49.5)

Broader instructions also apply from T36-T50 Poisoning by, adverse effects of and underdosing of drugs, medicaments and biological substances and Chapter 19: Injury, poisoning and certain other consequences of external causes.

MS-DRG v44.0 grouping

All DRGs →

Inpatient MS-DRGs this diagnosis can group to, as the principal or a secondary diagnosis, depending on the rest of the claim.

ICD-9-CM equivalent

Converter →
  • 960.2Poisoning by chloramphenicol groupapproximate, combination
  • E962.0Assault by drugs and medicinal substancesapproximate, combination

From the CMS 2018 General Equivalence Mappings (GEMs), the final GEMs release.

Code history

  1. 2016
  2. 2017
  3. 2018
  4. 2019
  5. 2020
  6. 2021
  7. 2022
  8. 2023
  9. 2024
  10. 2025
  11. 2026
  12. 2027
  • FY2016 (effective 10/1/2015): Added (first year of ICD-10-CM)
  • No changes since FY2016.

Common questions about T36.2X3A

Is T36.2X3A billable?

Yes. T36.2X3A is a billable/specific ICD-10-CM code valid for FY2027 (October 1, 2026 – September 30, 2027).

What does the "A" at the end of T36.2X3A mean?

It is the 7th character for initial encounter. Per the official guidelines, use it while the patient is receiving active treatment for the condition.

Can T36.2X3A be used as a principal diagnosis?

Yes. The Medicare Code Editor doesn't restrict T36.2X3A as a principal diagnosis.

Is T36.2X3A a CC or MCC?

No. T36.2X3A is neither a CC nor an MCC under MS-DRG v44.0.

What DRG does T36.2X3A group to?

T36.2X3A is used in the MS-DRG v44.0 logic for MS-DRG 917 (Poisoning and Toxic Effects of Drugs with MCC) and MS-DRG 918 (Poisoning and Toxic Effects of Drugs without MCC). Which one applies depends on whether it is the principal diagnosis and on the rest of the claim.

What is the ICD-9 code for T36.2X3A?

The CMS General Equivalence Mappings map T36.2X3A to ICD-9-CM 960.2 and E962.0.